Abbvie Endocrine Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBVIE ENDOCRINE INC, and what generic alternatives to ABBVIE ENDOCRINE INC drugs are available?
ABBVIE ENDOCRINE INC has six approved drugs.
There are two US patents protecting ABBVIE ENDOCRINE INC drugs.
There are thirty-five patent family members on ABBVIE ENDOCRINE INC drugs in twenty-eight countries.
Summary for Abbvie Endocrine Inc
International Patents: | 35 |
US Patents: | 2 |
Tradenames: | 3 |
Ingredients: | 1 |
NDAs: | 6 |
Drugs and US Patents for Abbvie Endocrine Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-002 | Apr 16, 1993 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-003 | Apr 16, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-002 | May 30, 1997 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Abbvie Endocrine Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-004 | Apr 16, 1993 | 5,476,663 | ⤷ Sign Up |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020517-001 | Dec 22, 1995 | 4,954,298 | ⤷ Sign Up |
Abbvie Endocrine Inc | LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020708-001 | Mar 7, 1997 | 5,476,663 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Abbvie Endocrine Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 101563068 | ⤷ Sign Up |
Canada | 2671670 | ⤷ Sign Up |
Chile | 2007003658 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.